Regorafenib 40 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Regorafenib 40 mg Tablets Specification

Indication
Used for the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma

Dosage Form
Tablets

Salt Composition
Regorafenib 40 mg

Feature
Multi-kinase inhibitor for oral use

Ingredients
Regorafenib and excipients

Application
Pharmaceutical, Oncology

Physical Color/Texture
Light yellow colored, film-coated tablets

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

Administration Route
Oral

Prescription Status
Prescription only

Strength
40 mg per tablet

Brand Name
Various (e.g., Stivarga or generic equivalents)

Global Certification
WHO-GMP, ISO certified manufacturing

Packaging Size
28 tablets per box (commonly available)

Regorafenib 40 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Regorafenib 40 mg Tablets

Discover the trending Regorafenib 40 mg Tablets, a prodigious innovation in oncology treatment. With a packaging size of 28 gorgeous, light yellow film-coated tablets per box, each tablet contains 40 mg of Regorafenib. This astounding oral medication is globally recognized (WHO-GMP and ISO certified) for treating metastatic colorectal cancer, GIST, and hepatocellular carcinoma. Buy now from suppliers and traders in India and Add to Cart for prescription-only use. Experience impeccable efficacy with Regorafenib's multi-kinase inhibitor action and a 24-month shelf life.

Regorafenib 40 mg Tablets: Application and Key Features

Regorafenib 40 mg Tablets are primarily used in the pharmaceutical and oncology sectors for the management of metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. This medication showcases a multi-kinase inhibitor profile and is widely respected for its efficacy and reliability. Administered orally, the tablets are used by oncologists and cancer treatment centers globally. Each film-coated tablet is designed for optimal patient compliance, backed by certifications for quality and safety.

Sample Policy and Domestic Market Availability

Our sample policy for Regorafenib 40 mg Tablets ensures accessibility for interested buyers within the main domestic market, India. Samples are available upon request, with a nominal charge covering the outlay and dispatching process. We prioritize customer satisfaction and transparency, making it straightforward for healthcare providers and institutions to assess product suitability and quality before committing to larger orders. Prompt dispatching of samples ensures convenience and efficiency throughout the ordering experience.

FAQ's of Regorafenib 40 mg Tablets:

Q: How should Regorafenib 40 mg Tablets be stored for best results?

A: Regorafenib 40 mg Tablets should be stored below 30C, protected from moisture and light, to maintain their potency and extend shelf life up to 24 months.

Q: What are the main benefits of choosing Regorafenib 40 mg for cancer treatment?

A: Regorafenib 40 mg offers a prodigious benefit as a multi-kinase inhibitor, effectively managing metastatic colorectal cancer, GIST, and hepatocellular carcinoma when prescribed by a medical professional.

Q: What is the process for purchasing samples of Regorafenib 40 mg Tablets in India?

A: Samples can be requested with a modest outlay covering dispatching and handling charges, ensuring you can review the product's quality before making a larger purchase.

Q: Who typically uses Regorafenib 40 mg Tablets?

A: These tablets are used by oncologists and healthcare professionals, prescribed to patients battling certain forms of cancer such as metastatic colorectal cancer, gastrointestinal stromal tumors, and advanced liver cancer.

Q: How is Regorafenib 40 mg administered in clinical practice?

A: Regorafenib 40 mg is administered orally, typically as one light yellow, film-coated tablet daily, under the direct supervision of an oncologist or specialist.

Tell us about your requirement